CORDRAN® Tape (Flurandrenolide, USP) may cause a condition called hypothalamic-pituitary-adrenal (HPA) axis suppression which can manifest in symptoms such as fatigue, suppressed immune system, depression, and anxiety. It may also cause Cushing’s syndrome (a hormonal disorder), high blood sugar, and glucose in the urine. Patients receiving a large dose to a large surface area should be evaluated periodically for evidence of HPA axis suppression. If symptoms of HPA axis suppression or irritation occur, or if you have a skin infection that is not under control, you should stop using CORDRAN® Tape and call your doctor. Children may be more at risk to experience serious side effects.
The most common side effects of products like CORDRAN® Tape are burning, itching, irritation, dryness, inflamed hair follicles, abnormal hair growth, inflammation of the skin, loss of skin color, rash on the face, and allergic skin rash.
For more information on CORDRAN® Tape, please see the full Prescribing Information
- CORDRAN Tape [package insert]. Exton, PA: Almirall, LLC, 2019.
- Ference JD, Last AR. Choosing topical corticosteroids. Am Fam Physician. 2009;79(2):135-140.
- US Department of Health and Human Services. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. 40th ed. US Food and Drug Administration; 2020. Accessed August 20, 2020. https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book
- Weiner MA. Flurandrenolone tape. A new preparation for occlusive therapy. J Invest Dermatol. 1966;47(1):63-66.
- Mullins TB, Sharma P, Sonthalia S. Prurigo Nodularis. Treasure Island, FL: StatPearls Publishing; 2019.
- Fonacier L, Bernstein DI, Pacheco K, et al. Contact dermatitis: a practice parameter-update 2015. J Allergy Clin Immunol Pract. 2015;3(3 Suppl):S1-39.
- Hand eczema. National Eczema Association. Accessed August 20, 2020. https://nationaleczema.org/eczema/types-of-eczema/hand-eczema.